San Francisco-based robotics company whose cloud-controlled robotic clusters automate cell, gene and biologics manufacturing processes, helping pharmaceutical companies increase capacity and reduce contamination risk without building new facilities.
NantWorks’ Patrick Soon-Shiong has led new funding rounds for manufacturing startups Prolific Machines and Multiply Labs, backing efforts to scale biologics and cell therapy production.